| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.009 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |